Detalles de la búsqueda
1.
High frequency of hyperglycaemia observed during CAR T-cell treatment.
Diabet Med
; 40(2): e14969, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209376
2.
Non-small-cell lung cancer infiltrated with chronic myelomonocytic leukaemia: a molecular diagnostic challenge to recognise mixed cancers in a single biopsy.
Histopathology
; 78(7): 1043-1046, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33410163
3.
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
Blood Cancer J
; 14(1): 41, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448432
4.
Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation.
Comput Struct Biotechnol J
; 21: 1102-1114, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789266
5.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
JCO Oncol Pract
; 19(3): e407-e416, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36508702
6.
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001703
7.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
EClinicalMedicine
; 61: 102040, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337616
8.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Cancers (Basel)
; 15(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686611
9.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv
; 7(11): 2645-2655, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058479
10.
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
JAMA Oncol
; 8(10): 1477-1483, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35951338
11.
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Blood Adv
; 6(5): 1537-1546, 2022 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114690
12.
[New treatment for patients with therapy-resistant lymphoma: CD19-targeted chimeric antigen receptor (CAR) T-cell therapy]. / Nieuwe hoop voor patiënten met uitbehandelde lymfeklierkanker.
Ned Tijdschr Geneeskd
; 1652021 08 19.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-34523851
13.
Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment.
Hemasphere
; 5(2): e523, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33458595
14.
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther
; 27(12): 999.e1-999.e10, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543768
15.
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
Blood Adv
; 7(21): 6710-6716, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639324
16.
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma.
Blood Adv
; 6(12): 3606-3610, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35271707
Resultados
1 -
16
de 16
1
Próxima >
>>